Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition.

Theunissen EL, Street D, Højer AM, Vermeeren A, van Oers A, Ramaekers JG.

Clin Pharmacol Ther. 2013 Jun;93(6):493-501. doi: 10.1038/clpt.2013.39. Epub 2013 Feb 20.

PMID:
23588319
2.

Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.

Ramaekers JG.

J Clin Psychiatry. 2003 Jan;64(1):20-9. Review.

PMID:
12590619
3.

Vortioxetine for the treatment of major depressive disorder.

Tritschler L, Felice D, Colle R, Guilloux JP, Corruble E, Gardier AM, David DJ.

Expert Rev Clin Pharmacol. 2014 Nov;7(6):731-45. doi: 10.1586/17512433.2014.950655. Epub 2014 Aug 28. Review.

PMID:
25166025
4.

Pharmacokinetic evaluation of vortioxetine for the treatment of major depressive disorder.

Dubovsky SL.

Expert Opin Drug Metab Toxicol. 2014 May;10(5):759-66. doi: 10.1517/17425255.2014.904286. Epub 2014 Apr 1. Review.

PMID:
24684240
5.

Vortioxetine : a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder.

Al-Sukhni M, Maruschak NA, McIntyre RS.

Expert Opin Drug Saf. 2015 Aug;14(8):1291-304. doi: 10.1517/14740338.2015.1046836. Epub 2015 May 28. Review.

PMID:
26022537
7.
8.

Vortioxetine for the treatment of depression.

Pearce EF, Murphy JA.

Ann Pharmacother. 2014 Jun;48(6):758-65. doi: 10.1177/1060028014528305. Epub 2014 Mar 27. Review.

PMID:
24676550
9.
10.

The effects of sertraline on psychomotor performance in elderly volunteers.

Hindmarch I, Shillingford J, Shillingford C.

J Clin Psychiatry. 1990 Dec;51 Suppl B:34-6. Review.

PMID:
2258380
11.

Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability.

Verster JC, Spence DW, Shahid A, Pandi-Perumal SR, Roth T.

Curr Drug Saf. 2011 Sep 1;6(4):209-18. Review.

PMID:
22129315
12.

An overview of vortioxetine.

Schatzberg AF, Blier P, Culpepper L, Jain R, Papakostas GI, Thase ME.

J Clin Psychiatry. 2014 Dec;75(12):1411-8. doi: 10.4088/JCP.14027ah1. Review.

13.

Vortioxetine: a review of its use in major depressive disorder.

Garnock-Jones KP.

CNS Drugs. 2014 Sep;28(9):855-74. doi: 10.1007/s40263-014-0195-x. Review.

PMID:
25145538
14.

Vortioxetine: A multimodal antidepressant or another selective serotonin reuptake inhibitor?

Keks NA, Hope J, Culhane C.

Australas Psychiatry. 2015 Jun;23(3):210-3. doi: 10.1177/1039856215581297. Epub 2015 Apr 23. Review.

PMID:
25907797
15.

Vortioxetine: A Review in Cognitive Dysfunction in Depression.

Frampton JE.

Drugs. 2016 Nov;76(17):1675-1682. Review.

PMID:
27807822
16.

Mirtazapine as positive control drug in studies examining the effects of antidepressants on driving ability.

Verster JC, van de Loo AJ, Roth T.

Eur J Pharmacol. 2015 Apr 15;753:252-6. doi: 10.1016/j.ejphar.2014.10.032. Epub 2014 Nov 13. Review.

PMID:
25446559
17.

[Driving fitness in therapy with antidepressive drugs].

Soyka M, Dittert S, Gartenmeier A, Schäfer M.

Versicherungsmedizin. 1998 Apr 1;50(2):59-66. Review. German.

PMID:
9587241
19.

Vortioxetine (Brintellix®) and levomilnacipran (Fetzima®): the two newest additions to the antidepressant formulary.

Roman MW, Wilkinson SM.

Issues Ment Health Nurs. 2014 Dec;35(12):972-4. doi: 10.3109/01612840.2014.955155. Review.

PMID:
25426751
20.

Histamine may contribute to vortioxetine's procognitive effects; possibly through an orexigenic mechanism.

Smagin GN, Song D, Budac DP, Waller JA, Li Y, Pehrson AL, Sánchez C.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jul 4;68:25-30. doi: 10.1016/j.pnpbp.2016.03.001. Epub 2016 Mar 2. Review.

PMID:
26945513

Supplemental Content

Support Center